Welcome to the Department of Radiation Oncology at the University of Colorado School of Medicine. Our mission is to provide the highest quality care to patients with all types of cancers and certain benign tumors. The department aims to achieve excellence in professionalism and performance of our services. We seek to create a climate that fosters innovation and allows patients access to the newest cutting edge treatments.
The Department of Radiation Oncology is integrated within the award-winning, nationally celebrated University of Colorado Hospital, within the larger University of Colorado Health system. The University of Colorado Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center.
In The News...
10/12/2018 - Dr. Priscilla Stumpf Joins Faculty
Dr. Priscilla Stumpf joined the faculty in July as Assistant Professor of Radiation Oncology. Dr. Stumpf attended the University of Southern Indiana as a recipient of the prestigious Baccalaureate/Doctor of Medicine scholarship awarding her a seat in the Indiana Univeristy School of Medicine upon completion of her undergraduate training. She received her MD at Indiana University School of Medicine and went on to complete her internship in the competitive Transitional Year program at IU Health Methodist in Indianapolis. She then completed her residency in radiation oncology here at the University of Colorado where she served as chief resident. During this time she has authored original research articles, abstracts, and textbook chapters with a special interest in stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS).
Dr. Stumpf will be providing clinical service at the main campus and elsewhere in other Metro Denver sites. She is especially looking forward to spending time at the Cherry Creek Medical Center when it opens in the Spring of 2020.
08/17/2018 - HIMRT vs IMRT for Localized Prostate Cancer
In a recent sudy, Dr. Thomas Pugh and colleagues compared the effects of hypofractionated, dose-escalated, intensity-modulated radiation therapy (HIMRT) against conventional IMRT for men with localized prostate cancer. After comparing the results of both methods, the team found that HIMRT demonstrated superior cancer control while shortening treatment duration. The full study is available is available to read here.
08/13/2018 - Schefter Wins First Place in Leadville 100
Dr. Tracy Schefter, Director of our Stereotactic Body Radiation Therapy program, took first place in the Leadville 100! Pictured right is Dr. Schefter mid-race. Congratulations, Dr. Schefter, on a victory well-earned!
5/11/18 - Goodman named ACR Fellow, will teach again at AACR/ASCO Research Workshop
Dr. Karyn Goodman, Associate Director of the University of Colorado Cancer Center and Grohne Professor of Clinical Oncology, is one of fifteen radiation oncologists and medical physicists to be approved this year for Fellowship by the American College of Radiology (ACR) Board of Chancellors. She will receive this honor at the 2018 Convocation, to be held in conjunction with the ACR Annual Meeting in May, 2018. Dr. Goodman will also again serve as a member of the faculty of the AACR/ASCO Methods in Clinical Cancer Research Workshop to be held from July 28-Aug. 3, 2018 in Vail, Colorado. The program is a very intensive and covers the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer. Attendees include clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation and surgical oncology and radiology. Interested participants must go through a competitive application process. The course is very highly regarded in the oncology community, and numerous current University of Colorado faculty members have studied there.
A recent study from Dr. Rusthoven and Dr. Robin challenges the use of whole-brain radiation for all small-cell lung cancer patients with brain metastases. The study, recently published in the journal Lung Cancer, compared the outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received stereotactic radiosurgery (SRS), finding that the median overall survival was actually longer with SRS (10.8 months with SRS versus 7.1 months with WBRT). Read the full article here
1/26/18 - Thomas awarded American Cancer Society Grant
Dr David Thomas, a member of the Medical Physics faculty, has been awarded an American Cancer Society Institutional Research Grant. The project titled “High Resolution X-Ray Induced Acoustic Computed Tomography for In-Vivo Dosimetry and Imaging Applications” is focused on developing a novel imaging system, which will provide real-time in-
vivo 3D radiation dose measurements in the body. “Radiation dosimetry (measuring the delivered radiation dose distribution) is a crucial part of improving the quality of radiation therapy in order to ensure that the correct dose is accurately delivered” says Dr. Thomas. “We hope to develop a system capable of measuring radiation dose in real time, based on the ‘photoacoustic effect’. I’m excited to apply this innovative technology to radiation therapy.
10/5/17 - Dr. Kavanagh delivers Presidental Address at ASTRO 2017
The ASTRO Annual Meeting is the world's most important meeting
for the radiation oncology community, with more than 11,000 people attending
each year. This comprehensive meeting covers all the latest developments in
radiation oncology, with a full program of scientific and educational sessions
that highlight the latest technological advances, while emphasizing the
importance of clinical care. The theme for the 59th Annual Meeting was “The
Healing Art and Science of Radiation Oncology”. Dr. Brian Kavanagh gave the
Presidential Address at the Annual ASTRO meeting in San Diego, CA in late
September and delivered a bit of poetry, a bit of science, and even a couple of
magic tricks framed by an individual patient’s story that set up a discussion
of larger narratives that have characterized the field of radiation oncology in
recent years. The entire presidential address can be seen at this link.
9/26/17 - CU Team Participates in ASTRO 5K
A team of past and present Physicians, Residents, Therapists, Dosimetrists, and Administrative Staff participated in the ASTRO ROI 5K Run For the Future
. Pictured below are all the participants from the race in San Diego on Monday September 25th. Special congratulations to our Physicist Jenia Vinogradskiy for finishing in 3rd place overall as well as organizing the CU team!
9/1/17 - Ridings named "Top Doc" once again
Dr. Jane Ridings has once again been named a “top doc” by Colorado Springs Style magazine. Dr. Ridings is the Medical Director of Radiation Oncology at Memorial Hospital in the University of Colorado Health System. She has earned this distinction for several years in a row as a result of her outstanding service in cancer care to the Colorado Springs Community. She has led numerous innovative clinical initiatives at Memorial, including an intra-operative radiation therapy (IORT) program for early stage breast cancer. The 2017 list can be seen here.
Jennifer Diamond, MD, and Christine
Fisher, MD, co-director of the Women’s Cancer Developmental Therapeutics
Program at the University of Colorado Cancer Center, help to increase access to
clinical trials and promising treatments for women with breast cancer and
gynecological cancers. Click here to read the full story.
8/14/17 - Rabinovitch and Liu recognized as Top Doctors again!
were once again recognized by 5280 magazine in the annual list of were once again recognized by 5280 magazine in the annual list of Top Doctors
in Denver. Each has received this distinction multiple times previously in view of their commitment to excellence in patient care and outstanding clinical skills. Dr. Rabinovitch is nationally and internationally known for her work in the treatment of breast cancer, serving at the lead investigator on numerous important clinical trials initiated locally and nationally through National Cancer Institute-sponsored NRG Oncology Group. She also maintains a long-standing collaboration with colleagues at the Shaare Zedek Medical Center in Jerusalem, Israel, the leading center for the study of women with the BRCA gene mutation. Dr. Liu specializes in the treatment of pediatric cancers. Among his many responsibilities is service on the Children’s Oncology Group (COG) Institutional Performance Monitoring Committee as well as the American Society for Radiation Oncology (ASTRO) Practice Accreditation Committee. He also serves as the Chief Medical Advisor to the Morgan Adams Foundation, which funds pediatric cancer research aimed at improving survival rates and reduce the side-effects cancer treatment.